Tughans advises the shareholders of healthcare software provider, Blue Zinc, on its sale to ClearCourse

Tughans has advised the shareholders of healthcare software provider, Blue Zinc, on its acquisition by ClearCourse, a leading group of innovative technology brands providing software solutions and an integrated payments platform.


Blue Zinc provides innovative solutions for the management of patient referrals, clinical pathways, and clinics for the physical (physiotherapy and wider musculoskeletal) and mental health segments in the healthcare sector. The company will form part of ClearCourse’s Business Services division and expands the latter’s growing footprint in the healthcare space.


Blue Zinc’s flagship digital solutions are designed to cater to a customer base with specialist demands: up to a thousand small- to medium-sized clinics deploy TM3, the company’s flagship clinic management product, while leading corporates such as Vita Health Group champion Blue Zinc’s Caseflow and Pronto solutions. Blue Zinc’s Corporate solutions enable the delivery of a range of healthcare services through the efficient digital management of patient referrals, clinical pathways and treatments. It provides an integrated digital platform for all stakeholders including funders, patients, case managers and clinics (including third party networks).


Tughans cross departmental M&A team was led by Partner and Head of Corporate, James Donnelly, with support from Corporate Director, Ben Sims, Corporate Associate, Tiarnan McKenna, and Employment Partner, Patricia Rooney.


See full press release here.


Commenting on the deal, James Donnelly, Partner and Head of Corporate at Tughans, said:

“We really enjoyed working with co-founders Ronnie Johnston and Kyle Lunn on this deal, which will enable Blue Zinc to enter a new ambitious and exciting phase as it continues to grow in the health tech space. We have acted for Blue Zinc for many years and this deal represents another success story for the local tech market.”